샘플 요청 목록

 카트 문의
시장보고서
상품코드
1886125

세계의 감염증 진단 시장

Infectious Disease Diagnostics
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 259 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 감염증 진단 시장은 2030년까지 457억 달러에 달할 전망

감염증 진단 세계 시장은 2024년에 331억 달러로 추정되며, 2024년부터 2030년까지의 분석 기간 동안 CAGR 5.5%로 성장하여 2030년까지 457억 달러에 달할 것으로 예상됩니다. 이 보고서에서 분석 대상이 된 부문 중 하나인 어세이·시약은 4.9%의 CAGR을 기록하며 분석 기간 종료시 점에서 258억 달러에 달할 것으로 예측됩니다. 또한 기기 부문의 성장률은 분석 기간 동안 6.5%의 CAGR로 추정됩니다.

미국 시장은 87억 달러로 추정되는 한편 중국은 8.2%의 CAGR로 성장할 것으로 예측됩니다

미국의 감염증 진단 시장은 2024년에 87억 달러로 추정됩니다. 세계 2위의 경제 규모를 자랑하는 중국은 2024년부터 2030년까지의 분석 기간 동안 CAGR 8.2%를 기록하며 2030년까지 102억 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안 각각 CAGR 2.9%, 5.1%로 성장할 것으로 예측됩니다. 유럽에서는 독일이 약 3.3%의 CAGR로 성장할 것으로 전망됩니다.

감염증 진단 시장 - 주요 시장 동향과 촉진요인 개요

감염병 진단이란 무엇이며, 왜 공중보건에 중요한가?

감염병 진단은 인체 검체에서 세균, 바이러스, 곰팡이, 기생충 등 병원균의 존재를 확인하기 위해 사용되는 검사 및 절차를 말합니다. 이러한 진단 기술은 감염병을 조기에 발견, 진단, 관리할 수 있게함으로써 감염 확산을 방지하고 이환율과 사망률을 감소시켜 공중보건의 근간이 됩니다. 사용되는 기술에는 전통적인 배양 기술, 혈청학적 검사, 중합효소 연쇄 반응(PCR) 및 차세대 시퀀싱과 같은 첨단 분자 기법이 포함됩니다. 이러한 도구는 COVID-19와 같은 집단 감염 상황에서 신속한 확진자 확인과 격리가 매우 중요한 상황에서 필수적입니다. 바이오메디컬 과학의 발전으로 진단의 유효성은 지속적으로 향상되고 있으며, 보다 정확하고 신속하며 비용 효율적인 검사를 실현하는 데 기여하고 있습니다.

기술 발전은 감염병 진단의 전망을 어떻게 바꾸고 있는가?

감염병 진단 분야는 눈부신 기술 발전으로 재편되고 있습니다. POC(Point-of-Care) 검사 장비와 같은 혁신으로 전문 검사 시설이 필요 없이 현장에서 신속한 진단이 가능해져 원격지나 자원이 제한된 환경에서의 질병 진단이 용이해졌습니다. 또한, 질병 발생을 실시간으로 추적하는 의료 정보 시스템을 포함한 디지털 헬스 기술의 통합으로 질병 모니터링과 대응의 효율성을 높이고 있습니다. 분자진단 기술, 특히 PCR 및 CRISPR 기반 진단법은 병원체를 고감도, 고특이도로 검출할 수 있다는 점에서 이 분야에 혁명을 일으켰습니다. 이러한 발전은 진단 능력을 향상시킬 뿐만 아니라, 진단 결과에 따라 환자 개개인의 필요에 맞는 치료법을 가능하게 하는 맞춤형 치료 접근법을 촉진하는 데에도 기여하고 있습니다.

감염병 진단 시장에 영향을 미치는 세계 동향은?

감염병 진단 시장에 영향을 미치는 세계 동향으로는 특히 감염병 발생률 증가와 결핵, 말라리아 등의 질병 재유행을 들 수 있습니다. 도시화와 국제 이동의 활성화는 감염병의 급속한 확산에 기여하고 있으며, 효과적인 진단 도구의 필요성을 강조하고 있습니다. 기후 변화도 한 요인으로 작용하고 있으며, 기온과 강수 패턴의 변화가 매개체 감염증의 분포에 영향을 미쳐 진단 수요를 증가시키고 있습니다. 또한, 항균제 내성 증가로 인해 내성 병원체를 신속하게 식별하고 적절한 치료 결정을 내릴 수 있는 진단법 개발이 시급한 상황입니다. 이러한 추세는 풍토병과 신종 감염병을 모두 관리하기 위해 전 세계적으로 배포할 수 있는 강력하고 확장 가능한 진단 솔루션을 필요로 합니다.

감염병 진단 시장의 성장은 여러 요인에 의해 주도되고 있습니다.

감염병 진단 시장의 성장은 기술 혁신, 역학적 변화, 의료 인프라의 발전 등 여러 요인에 의해 촉진되고 있습니다. 보다 신속하고 정확하며 비용 효율적인 진단 검사를 제공하는 기술 발전은 전염병 발생과 풍토병을 효과적으로 관리할 수 있는 능력을 향상시키는 데 있어 매우 중요합니다. 국제 이동의 증가와 도시화 등의 요인으로 인해 전 세계적으로 증가하는 감염병의 부담도 첨단 진단법에 대한 수요를 촉진하는 데 중요한 역할을 하고 있습니다. 또한, 예방 의료와 조기 진단에 초점을 맞춘 정부 및 의료 정책이 시장 확대에 큰 영향을 미치고 있습니다. 특히 개발도상국의 의료 인프라에 대한 투자는 진단 서비스에 대한 접근성 확대를 가능하게 하여 시장 성장을 더욱 촉진하고 있습니다. 소비자 행동, 특히 COVID-19 팬데믹 이후 건강 및 예방 조치에 대한 인식이 높아짐에 따라 일상적인 의료 행위에서 이러한 진단 방법의 채택이 지속적으로 증가하고 있습니다. 이러한 복합적인 요인은 전 세계가 보다 적극적이고 예방적인 의료 전략으로 전환하는 것을 반영하며, 감염성 질환 진단 시장의 역동적인 확장을 뒷받침하고 있습니다.

부문:

제품(분석시약, 기기, 소프트웨어) 기술(면역진단, 임상 미생물학, PCR, INAAT, DNA 시퀀싱 및 NGS, DNA 마이크로어레이, 기타 기술)

조사 대상 기업 예시

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • DiaSorin SpA
  • Luminex Corporation
  • Meridian Bioscience, Inc.
  • Quidel Corporation
  • Roche Diagnostics(Schweiz)AG
  • Siemens AG
  • Thermo Fisher Scientific, Inc.

AI 통합

검증된 전문가 컨텐츠와 AI 툴을 통해 시장 및 경쟁 정보 분석을 혁신하고 있습니다.

Market Glass, Inc.는 LLM이나 산업 특화형 SLM을 쿼리하는 일반적인 방식이 아닌, 전 세계 도메인 전문가들이 엄선한 컨텐츠 리포지토리를 구축했습니다. 여기에는 비디오 전사, 블로그, 검색 엔진 조사, 그리고 방대한 양의 기업, 제품/서비스, 시장 데이터가 포함됩니다.

관세 영향 계수

Market Glass, Inc.가 본사 소재지, 생산기지, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측하는 가운데, 이번 보고서에서는 지리적 시장에 대한 관세의 영향을 반영하였습니다. 이러한 복잡하고 다면적인 시장 현실은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 경쟁사에게 다양한 영향을 미치며, 미시적 및 거시적 시장 역학에도 영향을 미칩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSM 25.12.18

Global Infectious Disease Diagnostics Market to Reach US$45.7 Billion by 2030

The global market for Infectious Disease Diagnostics estimated at US$33.1 Billion in the year 2024, is expected to reach US$45.7 Billion by 2030, growing at a CAGR of 5.5% over the analysis period 2024-2030. Assays & Reagents, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$25.8 Billion by the end of the analysis period. Growth in the Instruments segment is estimated at 6.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$8.7 Billion While China is Forecast to Grow at 8.2% CAGR

The Infectious Disease Diagnostics market in the U.S. is estimated at US$8.7 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$10.2 Billion by the year 2030 trailing a CAGR of 8.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.9% and 5.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.

Infectious Disease Diagnostics Market - Key Trends & Drivers Summarized

What Are Infectious Disease Diagnostics and Why Are They Fundamental to Public Health?

Infectious disease diagnostics comprise tests and procedures used to identify the presence of pathogens like bacteria, viruses, fungi, or parasites in human samples. These diagnostics are fundamental to public health as they enable early detection, diagnosis, and management of infections, thereby preventing their spread and reducing morbidity and mortality. Technologies utilized include traditional culture techniques, serological assays, and advanced molecular methods like polymerase chain reaction (PCR) and next-generation sequencing. These tools are vital in outbreak situations, such as the COVID-19 pandemic, where rapid identification and isolation of cases are critical. The effectiveness of diagnostics is continually enhanced by advancements in biomedical science, contributing to more accurate, faster, and cost-effective tests.

How Is Technological Advancement Shaping the Landscape of Infectious Disease Diagnostics?

The landscape of infectious disease diagnostics is being reshaped by significant technological advancements. Innovations such as point-of-care (POC) testing devices allow for rapid, on-site diagnosis without the need for specialized laboratory facilities, making it easier to diagnose diseases in remote or resource-limited settings. Additionally, the integration of digital health technologies, including health information systems that track disease outbreaks in real time, is improving the efficiency of disease surveillance and response. Molecular diagnostic techniques, particularly PCR and CRISPR-based diagnostics, have revolutionized the field by providing high sensitivity and specificity in detecting pathogens. These advancements not only enhance diagnostic capabilities but also facilitate personalized treatment approaches, tailoring interventions to individual patient needs based on diagnostic results.

What Global Trends Are Influencing the Infectious Disease Diagnostics Market?

Several global trends are influencing the infectious disease diagnostics market, notably the increasing incidence of infectious diseases and the resurgence of conditions such as tuberculosis and malaria. Urbanization and global travel contribute to the rapid spread of infections, highlighting the need for effective diagnostic tools. Climate change also plays a role, as changing temperatures and precipitation patterns affect the distribution of vector-borne diseases, increasing the demand for diagnostics. Furthermore, the rise in antimicrobial resistance is prompting the development of diagnostics that can quickly identify resistant pathogens and guide appropriate treatment decisions. These trends necessitate robust, scalable diagnostic solutions that can be deployed globally to manage both endemic diseases and emerging infections.

Growth in the Infectious Disease Diagnostics Market Is Driven by Several Factors

The growth in the infectious disease diagnostics market is driven by several factors, including technological innovations, epidemiological shifts, and healthcare infrastructure developments. Technological advances that offer quicker, more accurate, and cost-effective diagnostic tests are crucial, as they improve the capacity to manage outbreaks and endemic diseases effectively. The increasing global burden of infectious diseases, driven by factors such as increased international travel and urbanization, also plays a significant role in fueling the demand for advanced diagnostics. Additionally, government and healthcare policies focusing on preventive care and early diagnosis are significantly influencing market expansion. Investments in healthcare infrastructure, particularly in developing regions, are enabling wider access to diagnostic services, further propelling market growth. Consumer behavior, especially heightened awareness regarding health and preventive measures following the COVID-19 pandemic, continues to drive the adoption of these diagnostics in routine healthcare practices. These combined factors underscore the dynamic expansion of the infectious disease diagnostics market, reflecting a global shift towards more proactive and preventive healthcare strategies.

SCOPE OF STUDY:

The report analyzes the Infectious Disease Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Assays & Reagents, Instruments, Software); Technology (Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray, Other Technologies)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 213 Featured) -

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • DiaSorin SpA
  • Luminex Corporation
  • Meridian Bioscience, Inc.
  • Quidel Corporation
  • Roche Diagnostics (Schweiz) AG
  • Siemens AG
  • Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • Infectious Disease Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Incidence of Infectious Diseases Spurs Demand for Advanced Diagnostic Solutions
    • Advancements in Molecular Diagnostics Propel Growth in Infectious Disease Testing
    • COVID-19 Pandemic Throws the Spotlight on Importance of Rapid and Point-of-Care Diagnostics
    • Increasing Focus on Early Detection and Prevention Expands Addressable Market for Infectious Disease Diagnostics
    • Growing Need for Accurate and Rapid Diagnostic Results Strengthens Business Case for Innovative Technologies
    • Emergence of Multiplex Diagnostic Platforms Generates Opportunities for Comprehensive Disease Screening
    • The Role of Artificial Intelligence and Machine Learning in Enhancing Diagnostic Accuracy Sustains Market Growth
    • Rising Investment in Healthcare Infrastructure in Emerging Markets Propels Demand for Infectious Disease Diagnostics
    • Increasing Consumer Awareness and Access to Testing Drives Adoption of At-Home Diagnostic Kits
    • Growing Emphasis on Personalized Medicine and Targeted Therapies Expands Use of Precision Diagnostics
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Immunodiagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Immunodiagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Immunodiagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for PCR by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Infectious Disease Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Infectious Disease Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Infectious Disease Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Assays & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Assays & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Assays & Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Clinical Microbiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Clinical Microbiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Clinical Microbiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for INAAT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for INAAT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for INAAT by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for DNA Sequencing & NGS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for DNA Sequencing & NGS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for DNA Sequencing & NGS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for DNA Microarray by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for DNA Microarray by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for DNA Microarray by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Infectious Disease Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • JAPAN
    • Infectious Disease Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • CHINA
    • Infectious Disease Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: China 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • EUROPE
    • Infectious Disease Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Infectious Disease Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Infectious Disease Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • FRANCE
    • Infectious Disease Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 68: France Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: France 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 71: France Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: France 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • GERMANY
    • Infectious Disease Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Germany 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Germany 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Italy 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Italy 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Infectious Disease Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 86: UK Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: UK 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 89: UK Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: UK 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Spain 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 95: Spain Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Spain Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Spain 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Russia 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 101: Russia Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Russia Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Russia 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of Europe 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 107: Rest of Europe Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of Europe Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Rest of Europe 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Infectious Disease Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Infectious Disease Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Asia-Pacific 15-Year Perspective for Infectious Disease Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Asia-Pacific 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Infectious Disease Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Australia 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 122: Australia Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Australia Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Australia 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • INDIA
    • Infectious Disease Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 125: India Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: India 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 128: India Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: India Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: India 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: South Korea 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 134: South Korea Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: South Korea Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: South Korea 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Asia-Pacific Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Asia-Pacific 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Infectious Disease Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Latin America 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Infectious Disease Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Latin America 15-Year Perspective for Infectious Disease Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 149: Latin America Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Latin America Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Latin America 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 152: Argentina Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Argentina Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Argentina 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 155: Argentina Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Argentina Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Argentina 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 158: Brazil Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Brazil Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Brazil 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 161: Brazil Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Brazil Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Brazil 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 164: Mexico Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Mexico Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Mexico 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 167: Mexico Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Mexico Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Mexico 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Rest of Latin America Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Rest of Latin America 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 173: Rest of Latin America Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Rest of Latin America Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Rest of Latin America 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Infectious Disease Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Middle East 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Infectious Disease Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Middle East 15-Year Perspective for Infectious Disease Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 182: Middle East Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Middle East Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Middle East 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 185: Iran Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Iran Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Iran 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 188: Iran Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Iran Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Iran 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 191: Israel Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Israel Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Israel 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 194: Israel Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Israel Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Israel 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Saudi Arabia Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Saudi Arabia 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 200: Saudi Arabia Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Saudi Arabia Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Saudi Arabia 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 203: UAE Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: UAE Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: UAE 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 206: UAE Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: UAE Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: UAE 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Rest of Middle East Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Rest of Middle East 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 212: Rest of Middle East Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Rest of Middle East Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Rest of Middle East 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • AFRICA
    • Infectious Disease Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 215: Africa Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Africa Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Africa 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 218: Africa Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Africa Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Africa 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제